CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
1,970.00
+21.00 (1.08%)
Apr 1, 2025, 3:30 PM KST
CMG Pharmaceutical Revenue
In the year 2024, CMG Pharmaceutical had annual revenue of 99.10B KRW with 5.53% growth. CMG Pharmaceutical had revenue of 26.72B in the quarter ending December 31, 2024, with 21.54% growth.
Revenue
99.10B
Revenue Growth
+5.53%
P/S Ratio
2.82
Revenue / Employee
363.00M
Employees
273
Market Cap
273.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 99.10B | 5.19B | 5.53% |
Dec 31, 2023 | 93.91B | 11.71B | 14.25% |
Dec 31, 2022 | 82.20B | 23.57B | 40.21% |
Dec 31, 2019 | 58.62B | 8.76B | 17.56% |
Dec 31, 2018 | 49.86B | 8.33B | 20.05% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |